2015 Indication and management of allogeneic stem cell transplantation in primary myelofibrosis: a consensus process by an EBMT/ELN international working group. Group Chronic Malignancies Working Party (CMWP) 1st listed author Kröger NM Journal Leukemia
2015 Outcome of conditioning intensity in acute myeloid leukemia with monosomal karyotype in patients over 45 year-old: A study from the Acute Leukemia Working Party (ALWP) of the European group of Blood and Marrow Transplantation (EBMT). Group Acute Leukemia Working Party (ALWP) 1st listed author Poiré X Journal Am J Hematol.
2015 Comparison of upfront tandem autologous-allogeneic transplantation versus reduced intensity allogeneic transplantation for multiple myeloma. Group WP/Committee not specified 1st listed author Sahebi F Journal Bone Marrow Transplant.
2015 Second allogeneic transplantation for relapse of malignant disease: retrospective analysis of outcome and predictive factors by the EBMT. Group Chronic Malignancies Working Party (CMWP) 1st listed author Ruutu T Journal Bone Marrow Transplant.
2015 Hematopoietic stem cell transplantation for T-cell large granular lymphocyte leukemia: a retrospective study of the European Society for Blood and Marrow Transplantation. Group Lymphoma Working Party (LWP) 1st listed author Marchand T Journal Leukemia
2015 Autologous Hematopoetic Stem Cell Transplantation for Refractory Crohn Disease: A Randomized Clinical Trial. Group Autoimmune Diseases Working Party (ADWP) 1st listed author Hawkey CJ Journal JAMA
2015 Thiotepa-based high-dose therapy for autologous stem cell transplantation in lymphoma: a retrospective study from the EBMT. Group Lymphoma Working Party (LWP) 1st listed author Sellner L Journal Bone Marrow Transplant.
2015 Indications for allo- and auto-SCT for haematological diseases, solid tumours and immune disorders: current practice in Europe, 2015. Group WP/Committee not specified 1st listed author Sureda A Journal Bone Marrow Transplant.
2015 Outcome of patients with distinct molecular genotypes and cytogenetically normal AML after allogeneic transplantation. Group Acute Leukemia Working Party (ALWP) 1st listed author Schmid C Journal Blood
2015 Conditioning intensity in middle-aged patients with AML in first CR: no advantage for myeloablative regimens irrespective of the risk group-an observational analysis by the Acute Leukemia Working Party of the EBMT. Group Acute Leukemia Working Party (ALWP) 1st listed author Passweg JR Journal Bone Marrow Transplant.
2015 Second allo-SCT in patients with lymphoma relapse after a first allogeneic transplantation. A retrospective study of the EBMT Lymphoma Working Party. Group Lymphoma Working Party (LWP) 1st listed author Horstmann K Journal Bone Marrow Transplant.
2015 High-Dose Chemotherapy With Autologous Hematopoietic Stem Cell Transplantation for High-Risk Primary Breast Cancer. Group Cellular Therapy & Immunobiology Working Party (CTIWP) 1st listed author Pedrazzoli P Journal J Natl Cancer Inst Monogr.